Wells Fargo’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-794
| Closed | -$13.8K | – | 7075 |
|
|
2024
Q1 | $13.8K | Buy |
794
+100
| +14% | +$1.74K | ﹤0.01% | 5282 |
|
|
2023
Q4 | $10.9K | Buy |
694
+135
| +24% | +$2.11K | ﹤0.01% | 5381 |
|
|
2023
Q3 | $27.7K | Sell |
559
-145
| -21% | -$7.18K | ﹤0.01% | 5106 |
|
|
2023
Q2 | $55.1K | Buy |
704
+451
| +178% | +$35.3K | ﹤0.01% | 5108 |
|
|
2023
Q1 | $22.9K | Buy |
253
+244
| +2,711% | +$22.1K | ﹤0.01% | 5268 |
|
|
2022
Q4 | $1.03K | Sell |
9
-24
| -73% | -$2.74K | ﹤0.01% | 5855 |
|
|
2022
Q3 | $6K | Sell |
33
-9
| -21% | -$1.64K | ﹤0.01% | 5541 |
|
|
2022
Q2 | $3K | Sell |
42
-7
| -14% | -$500 | ﹤0.01% | 5947 |
|
|
2022
Q1 | $8K | Sell |
49
-479
| -91% | -$78.2K | ﹤0.01% | 6005 |
|
|
2021
Q4 | $157K | Buy |
528
+527
| +52,700% | +$157K | ﹤0.01% | 5021 |
|
|
2021
Q3 | $0 | Sell |
1
-748
| -100% | – | ﹤0.01% | 7261 |
|
|
2021
Q2 | $340K | Buy |
749
+748
| +74,800% | +$340K | ﹤0.01% | 4527 |
|
|
2021
Q1 | $0 | Sell |
1
-454
| -100% | – | ﹤0.01% | 7068 |
|
|
2020
Q4 | $402K | Sell |
455
-165
| -27% | -$146K | ﹤0.01% | 4581 |
|
|
2020
Q3 | $392K | Buy |
+620
| New | +$392K | ﹤0.01% | 4406 |
|